Skip to content

Thinlith II Pulse Gneerator Model 227-05

by Intermedics, Inc. 510(k)

Active United States

510(k) K810386

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK810386 Date13 Mar 1981ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Thinlith II Pulse Generator Model 227-05 is an implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. This Class III device is intended for patients requiring consistent pacing support to manage bradycardia or other cardiac conduction disorders.

This device is supplied as a reusable, sterile medical implant, regulated under FDA 510(k) clearance (K810386) and classified under regulation 870.3610. It is intended for use in cardiovascular settings and must be implanted by qualified medical professionals. Storage and handling follow standard sterile implant protocols, with compliance ensured through FDA-authorized procedures.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Thinlith II Pulse Generator Model 227-05, and how does it achieve this?

    The Thinlith II Pulse Generator Model 227-05 is designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients with bradycardia or other cardiac conduction disorders who require consistent pacing support to maintain proper heart function. The device achieves this through implanted electrodes that stimulate the heart muscle when natural electrical signals are insufficient.

  • Is the Thinlith II Pulse Generator Model 227-05 intended for single-use or reusable applications, and what does this mean for clinical workflows?

    The Thinlith II Pulse Generator Model 227-05 is classified as a reusable device, meaning it is intended for multiple uses after proper sterilization and maintenance. This allows for cost-effective clinical workflows, as the device can be reprocessed and reused for subsequent patients, provided it adheres to sterile implant protocols and FDA-authorized procedures.

  • What storage and handling requirements must be followed for the Thinlith II Pulse Generator Model 227-05 to ensure sterility and compliance?

    The Thinlith II Pulse Generator Model 227-05 must be stored and handled according to standard sterile implant protocols, as it is supplied as a sterile medical implant. Compliance is ensured through FDA-authorized procedures, which include maintaining sterility before implantation and following rigorous reprocessing guidelines if reused. This ensures patient safety and regulatory adherence.

  • What regulatory pathway was followed for the FDA clearance of the Thinlith II Pulse Generator Model 227-05, and what does this imply for its use?

    The Thinlith II Pulse Generator Model 227-05 received FDA clearance through a Traditional 510(k) pathway (K810386) under regulation 870.3610, with a decision of Substantially Equivalent by the Cardiovascular (CV) Advisory Committee. This implies the device was evaluated for safety and effectiveness compared to a legally marketed predicate and is classified as a Class III device, requiring strict adherence to FDA guidelines for implantation and use in cardiovascular settings.